Visiongain Report Offers Transformative Insights on the $97bn Precision Medicine Market
LONDON, Aug. 6, 2019 /PRNewswire/ -- Companion Diagnostics, Biomarker-based Test, Targeted Therapeutics, Pharmacogenomics, Molecular Diagnostics, Pharmaceuticals & Biotechnology Companies, Diagnostic Companies, Healthcare IT/Big Data Companies, Clinical Laboratories, Cancer, Cardiovascular Diseases, Central Nervous System, Infectious Diseases
https://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg
The global precision medicine market is expected to grow at an estimated CAGR of 10.5% from 2018 to 2029. In the precision medicine market, the Diagnostic Tool companies' segment is dominating the global market and accounted for $23.36 billion in 2018 due to the development of large number of diagnostic and genetic tests.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 212-page report you will receive 98 tables and 63 figures- all unavailable elsewhere.
The 212-page report provides clear detailed insight into the global precision medicine market. Discover the key drivers and challenges affecting the market.
By ordering and reading Visiongain's brand-new report today you stay better informed and ready to act.
To request sample pages from this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/global-precision-medicine-market-forecast-2019-2029/#download_sampe_div
Report Scope
-- Global Precision Medicine Market forecasts from 2019-2029
-- Along with revenue prediction for the overall market for the global precision medicine market, our investigation shows forecasts to 2029 for the market segmented by technology:
- Companion Diagnostics
- Biomarker-based Test
- Targeted Therapeutics
- Pharmacogenomics
- Molecular Diagnostics
The report discusses key trends, developments and participants.
-- This report breaks down the precision medicine market forecast to 2029 by end-users:
- Pharmaceuticals & Biotechnology Companies
- Diagnostic Companies
- Healthcare IT/Big Data Companies
- Clinical Laboratories
The report discusses key trends, developments and participants.
-- This report also breaks down the precision medicine market forecast to 2029 by therapeutic application:
- Cancer
- Cardiovascular Diseases
- Central Nervous System
- Infectious Diseases
- Immunology
- Others
The report discusses key trends, developments and participants.
-- This study provides precision medicine market forecasts to 2029 for these regional markets:
- North America: US & Canada
- Europe: Germany, UK, France, Italy, Spain, Rest of Europe
- Asia-Pacific: China, japan, India, Australia, South Korea, Rest of Asia-Pacific
- Middle East & Africa: South Africa, Saudi Arabia, Rest of Middle East & Africa
- Latin America: Brazil, Mexico, Rest of Latin America
For each regional market, the report discusses key trends, developments and participants.
-- This report profiles selected leading companies that are the main players in the global precision medicine market:
- Abbott
- Danaher Corporation
- GE Healthcare
- GlaxoSmithKline
- Illumina, Inc.
- Johnson & Johnson
- Laboratory Corporation of America Holdings
- Novartis
- Pfizer
- QIAGEN
- Thermo Fisher Scientific, Inc.
-- Our study discusses the drivers, restraints as well as the opportunities in the global precision medicine market.
-- This study also analyzed the global precision medicine market with Porter's Five Forces Analysis as well as Value Chain Analysis
-- This report discusses selected market developments in the precision medicine market: partnership, collaboration, join venture, acquisitions, product launch, product development, expansions, patents, approvals.
To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/global-precision-medicine-market-forecast-2019-2029/
Did you know that we also offer a report add-on service? Email sara.peerun@visiongain.com to discuss any customized research needs you may have.
Companies covered in the report include:
23andMe
Abbott
Abbott Molecular Inc.
Abcodia
ACS Biomarker
Actelion Pharmaceuticals Ltd.
Advanced Biological Laboratories
Affymetrix, Inc.
Agendia BV
Alacer Corp
Alberta Cancer Research Biobank
Alios BioPharma, Inc.
Almac
Almac Diagnostics
Amgen
Apple
Archimedes
Aspen
Astellas Pharma Inc.
Astrazeneca plc
Astute Medical
Asuragen, Inc.
AT&T
AthenaHealth, Inc.
Aurora
Auspex Pharmaceuticals, Inc.
Avon Longitudinal Study of Parents and Children
BGI Tech Solutions Co., Ltd.
BioFortis
BioGene
bioMerieux, Inc.
Bode Technology Group, Inc.
CareWell Urgent Care
Caris
Celera Diagnostics
Cell & Co Biorepository
Celtics Healthcare
Cepheid
CFR Pharmaceuticals
Ciba-Geigy
Clarient Diagnostic Services, Inc.
Cognizant
Cooperative Human Tissue Network
COPAN
Covance Inc.
Cubist Pharmaceuticals
Daiichi Sankyo Co. ltd.
Dako
Dako Denmark A/S
Dell
Diabeter
Eagle Pharmaceuticals, Inc.
Eli Lilly
Estonian Genome Project
Ferring Pharmaceuticals
Fisher BioServices
Flakka
Foundation Medicine
GE Healthcare
Genome Medicine
Genomic Health
GenoSpace
Gen-Probe, Inc.
GlaxoSmithKline (GSK)
Glooko
Google Inc.
Hologic, Inc.
Human Tissue Resource Network
HUNT Biobank
IBM
Idera Pharmaceuticals Inc.
Illumina, Inc.
Immuneering Corporation
Infectio Diagnostic, Inc.
Institutional Biobank of Lausanne
Intel
Intomics
Janssen Biotech Inc.
Japan Post Group
Johnson & Johnson
Kaiser Permanente
Lab-Ally LLC
Laboratory Corporation of America
LG
Life Technologies
llumina Inc.
Luminex Molecular Diagnostics Inc.
Lutron Electronics
Mayo Clinic
Medpace
Medtronic
Medtronic plc
Merck
Modul-Bio
Molecular Health
Monogram Bioscience
Myriad Genetic Laboratories, Inc.
Nanosphere, Inc.
NanoString
NextWave
Novartis
Omnyx, LLC
OncoMed Pharmaceuticals, Inc.
Oncotype DX
OneMedNet Corporation
Oracle Healthcare
Panasonic Healthcare
PATH Biobank
Pfizer
Philips Healthcare
ProMedDx
Q2 Solutions
Qiagen
Qiagen Manchester, Ltd.
Qualcomm
Qualcomm Life, Inc.
Quest Diagnostics
Randox Laboratories
Randox Toxicology
Reddy Laboratories
Roche
Roche Molecular Systems, Inc.
Royal Philips
Samsung
Sandoz
Sanofi Aventis
Sanofi Pharma
Siemens Clinical Lab
Siemens Healthcare
Signature Diagnostics AG
St. Jude Medical (SJM)
Sterand Plc
Syapse
Sysmex
Sysmex Corporation
Takeda Pharmaceuticals
Teva Pharmaceuticals
Therascreen
Topera, Inc
Trofile
U.K. Biobank
UMass Cancer Center Tissue and Tumor Bank
Ventana Medical Systems, Inc.
Veropharm
Vysis
Zinfandel Pharmaceuticals
List of Organizations Mentioned in the Report
Alberta Health Services
Alberta Tumour Bank
American Association for Cancer Research (AACR)
American Medical Association
American National Standards Institute (ANSI)
American Telemedicine Association
Association for Molecular Pathology
Beth Israel Deaconess Medical Center (BIDMC)
Biobank Japan-Riken Institute
Biobanque de Picardie
Biological Resources Centres
Canadian Biosample Repository
Canadian Federal Government
Canadian Institutes of Health Research (CIHR)
Cancer Research Network of the FRSQ
Capital Health/Regional Tissue Bank
Careggi University Hospital
Central Biomaterial Bank
Centre for Disease Control and Prevention (CDC)
Charité-Universitätsmedizin Berlin
Confederation of Cancer Biobanks
Danubian Biobank Consortium Tissue Bank
Drug Enforcement Agency (DEA)
European Association for Cancer Research (EACR)
European Diagnostics Manufacturers Association (EDMA)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Medicines Agency (EMA)
European Society of Human Genetics
Food and Drug Administration (FDA)
Genethon DNA and Cell Bank
German Heart Failure Network
Global Medical Technology Alliance (GMTA)
Health Science Research Resources Bank/Japan Health Science Foundation
Healthcare information and management systems society (HIMSS)
International Human Genome Sequencing Consortium
International Medical Device Regulators Forum (IMDRF)
Japan National Cancer Center Brain Bank for Aging Research
Japanese Collection of Research Bioresources
King's College Infectious Diseases Biobank
Liverpool Tissue Bank
Manitoba Breast Tumour Bank
National Institutes of Health (NIH)
NHS Cod Blood Bank
Norwegian University of Science and Technology
Office of the national coordinator for health information technology (ONC HIT)
Ohio State University
Ontario Cancer Research Network
Organization of European Cancer Institute (OECI)
Patient DNA collection at Institute of Human Genetics Heidelberg
Patient-Centered Outcomes Research Institute (PCORI)
Pharmaceutical and medical devices agency (PMDA)
PROCURE Quebec Prostate Cancer
Southwest France Tumour Bank
The Brain Tumour Tissue Bank
The Center for Assessment Technology and Continuous Health (CATCH)
The National Center for Toxicological Research (NCTR)
The National Health Services (NHS)
The National Institute for Health Research (NIHR)
Therapeutic Goods Administration (TGA)
Triangle Global Health Consortium
Tumour Bank of Provence
U.K. Biobank Roslin Wellcome Trust Tick Cell Biobank
U.K. DNA Banking Network
U.K. Stem Cell Bank
United Kingdom Clinical Research Network (UKCRN)
University Hospital of Lausanne and University of Lausanne
University of Bristol
University of Massachusetts Medical School
University of Tartu
Wireless-Life Sciences Alliance (WLSA)
World Health Organisation (WHO)
To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com
Related reports:
The Companion Diagnostics (CDx) Market Forecast 2018-2028
Medical Devices Leader Series: Top In Vitro Diagnostics (IVD) Companies 2019-2029
Global Genomics Market Report 2018-2028
The Next Generation Sequencing Market Forecast 2019-2029
Global Alzheimer's Disease Therapeutics and Diagnostics Market 2018-2028
Global Parkinson's Disease Drug Market Forecast 2018-2028
View original content:http://www.prnewswire.com/news-releases/visiongain-report-offers-transformative-insights-on-the-97bn-precision-medicine-market-300889472.html
SOURCE Visiongain
